KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $250,000 | -34.2% | 17,236 | -55.4% | 0.03% | -42.1% |
| Q2 2022 | $380,000 | +9.8% | 38,650 | +64.5% | 0.06% | +23.9% |
| Q1 2022 | $346,000 | +127.6% | 23,502 | +104.4% | 0.05% | +142.1% |
| Q4 2021 | $152,000 | -64.7% | 11,499 | -49.3% | 0.02% | -72.9% |
| Q4 2020 | $430,000 | +34.0% | 22,664 | -11.0% | 0.07% | +29.6% |
| Q3 2020 | $321,000 | +150.8% | 25,466 | +51.7% | 0.05% | +68.8% |
| Q1 2020 | $128,000 | -57.3% | 16,786 | -0.3% | 0.03% | -8.6% |
| Q4 2019 | $300,000 | +150.0% | 16,836 | +63.1% | 0.04% | +118.8% |
| Q3 2019 | $120,000 | -43.1% | 10,321 | +40.0% | 0.02% | -23.8% |
| Q1 2019 | $211,000 | – | 7,371 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |